These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7995329)

  • 41. Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteers.
    Day RO; Geisslinger G; Paull P; Williams KM
    Br J Clin Pharmacol; 1994 Jan; 37(1):79-81. PubMed ID: 8148224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tenoxicam-induced gastropathy in the rat: a comparison with piroxicam and diclofenac sodium, and the inhibitory effects of ranitidine and sucralfate.
    al-Ghamdi MS; Dissanayake AS; Cader ZA; Jain S
    J Int Med Res; 1991; 19(3):242-8. PubMed ID: 1936514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antipyretic effect of tenoxicam and paracetamol in febrile children.
    Similä S; Kylmämaa T
    Drugs Exp Clin Res; 1985; 11(10):731-4. PubMed ID: 3915461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A double-blind parallel study of tenoxicam and piroxicam in patients with osteoarthrosis.
    Bird HA; Hill J; Dixon JS; Looi D; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):53-9. PubMed ID: 3915888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of tenoxicam in experimental corrosive esophagitis model.
    Erbaş M; Kiraz HA; Küçük A; Topaloğlu N; Erdem H; Şahin H; Toman H; Ozkan MT
    Dis Esophagus; 2015 Apr; 28(3):253-7. PubMed ID: 24602009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of novel transdermal self-adhesive films for tenoxicam, an anti-inflammatory drug.
    Nesseem DI; Eid SF; El-Houseny SS
    Life Sci; 2011 Sep; 89(13-14):430-8. PubMed ID: 21777594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of formulated tenoxicam transdermal delivery systems.
    Kim T; Kang E; Chun I; Gwak H
    J Pharm Pharmacol; 2008 Jan; 60(1):135-8. PubMed ID: 18088513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative double blind study of the efficacy and safety of tenoxicam vs. piroxicam in osteoarthritis of knee and hip joints.
    Adelowo OO; Chukwuani CM; Grange JJ; Ojeasebhulo EE; Onabowale BO
    West Afr J Med; 1998; 17(3):194-8. PubMed ID: 9814091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of haemodialysis on the pharmacokinetics of tenoxicam in patients with end-stage renal disease.
    al-Ghamdi MS; al-Mohanna FA; al-Mustafa ZH; al-Saeed IS
    Eur J Clin Pharmacol; 1992; 43(2):197-9. PubMed ID: 1425878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
    Bird HA; Allen JG; Dixon JS; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):47-52. PubMed ID: 3879830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tenoxicam does not enhance the spread of sensory block produced by intrathecal lidocaine.
    Fassoulaki A; Sarantopoulos C; Zotou M
    Acta Anaesthesiol Belg; 1997; 48(4):233-8. PubMed ID: 9526601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lornoxicam in extracorporeal shock-wave lithotripsy; comparison with tenoxicam and placebo in terms of analgesic consumption.
    Bilir A; Gulec S; Turgut M; Cetinkaya D; Erkan A; Kurt I
    Scand J Urol Nephrol; 2008; 42(2):143-7. PubMed ID: 17853036
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-inflammatory activity and gastric lesions induced by zinc-tenoxicam.
    Nascimento JW; Santos LH; Nothenberg MS; Coelho MM; Oga S; Tagliati CA
    Pharmacology; 2003 Jun; 68(2):64-9. PubMed ID: 12711832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Scand J Rheumatol Suppl; 1987; 65():107-12. PubMed ID: 3317800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Double-blind randomized multicenter study with tenoxicam, piroxicam and diclofenac sodium retard in the treatment of ambulatory patients with arthroses and soft tissue rheumatism].
    Moser U; Waldburger M; Schwarz HA; Gobelet CA
    Schweiz Rundsch Med Prax; 1989 Mar; 78(10):263-9. PubMed ID: 2649954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Eur J Rheumatol Inflamm; 1987; 9(2):51-7. PubMed ID: 3329109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adjunctive treatment of decompression illness with a non-steroidal anti-inflammatory drug (tenoxicam) reduces compression requirement.
    Bennett M; Mitchell S; Dominguez A
    Undersea Hyperb Med; 2003; 30(3):195-205. PubMed ID: 14620099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of tenoxicam in human plasma by high-performance liquid chromatography.
    Heizmann P; Körner J; Zinapold K
    J Chromatogr; 1986 Jan; 374(1):95-102. PubMed ID: 3485110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of food and various antacids on the absorption of tenoxicam.
    Day RO; Lam S; Paull P; Wade D
    Br J Clin Pharmacol; 1987 Sep; 24(3):323-8. PubMed ID: 3499163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Piroxicam versus tenoxicam in spine surgery: a placebo controlled study.
    De Decker K; Vercauteren M; Hoffmann V; Lasters B; Adriaensen H
    Acta Anaesthesiol Belg; 2001; 52(3):265-9. PubMed ID: 11732382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.